Sexual Desire and Pharmacologic Management
- PMID: 38777482
- DOI: 10.1016/j.ogc.2024.03.004
Sexual Desire and Pharmacologic Management
Abstract
Female sexual desire is a complex interplay of neurotransmitters and hormones. Diagnosis is based on clinical features and sexual distress. Treatments that affect neurotransmitters and hormones that may be out of balance can help improve sexual desire in women with hypoactive sexual desire disorder.
Keywords: Hormones; Hypoactive sexual desire; Low libido; Neurotransmitters and sexual health.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr Rowen received consulting fees from MCG Health and has served on medical advisory boards for Sprout and Endo pharmaceuticals. Dr Simon receives Grant/research support from AbbVie, Inc., Bayer Healthcare LLC., Daré Bioscience; Ipsen, Mylan/Viatris Inc., Myovant Sciences, Sebela Pharmaceuticals Inc. Consultant/advisory boards: Bayer HealthCare Pharmaceuticals Inc., Besins Healthcare, Biote Medical, LLC, California Institute of Integral Studies (CIIS), Daré Bioscience, Femasys Inc., Khyria, Madorra Pty Ltd., Mayne Pharma, Inc., Pfizer Inc., Vella Bioscience Inc. Speaker's bureaus: Astellas Pharma, Inc., Mayne Pharma, Inc., Myovant Sciences, Inc., Pfizer Inc., Pharmavite LLC., Scynexis Inc. Stockholder (direct purchase): Sermonix Pharmaceuticals.
Similar articles
-
Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder.J Clin Psychiatry. 2010 Jul;71(7):821-2. doi: 10.4088/JCP.10bs06117blu. J Clin Psychiatry. 2010. PMID: 20667289 Review.
-
[Flibanserin as pharmacological therapy of inhibited sexual desire in women].Ugeskr Laeger. 2017 Feb 13;179(7):V03160209. Ugeskr Laeger. 2017. PMID: 28397671 Review. Danish.
-
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.Obstet Gynecol. 2019 Nov;134(5):899-908. doi: 10.1097/AOG.0000000000003500. Obstet Gynecol. 2019. PMID: 31599840 Free PMC article. Clinical Trial.
-
Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.J Sex Med. 2019 Dec;16(12):1885-1894. doi: 10.1016/j.jsxm.2019.09.005. Epub 2019 Oct 31. J Sex Med. 2019. PMID: 31678098 Clinical Trial.
-
Hypoactive sexual desire disorder: inventing a disease to sell low libido.J Med Ethics. 2015 Oct;41(10):859-62. doi: 10.1136/medethics-2014-102596. Epub 2015 Jun 29. J Med Ethics. 2015. PMID: 26124287
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
